Contact Us
Search:
Our CompanyPartnershipsProductsContract ManufacturingInvestor Relations
Welcome to Akorn

Stock Information

symbol AKRX open 3.75 change +0.06
last price 3.74 high 3.80 time 10:10am
date 9/3/2010 low 3.72 volume 70903
Stock price delayed 20 min, Time shown is time of last trade

In the Spotlight

Product Update Ephedrine Sulfate Injection
Akten™ - A New Horizon in Ocular Anesthesia
AK-Fluor® 10% and Paremyd® Available Now

Press Releases

Akorn Reports Second Quarter 2010 Financial Results; Core Revenues Increase by 138%; Adjusted EBITDA of $4.2 million; Raises Earnings Outlook for 2010
Akorn, Inc. Announces Second Quarter 2010 Earnings Release and Conference Call Information
Akorn Reports First Quarter 2010 Financial Results; Achieves Positive Operating Income from Strong Demand in Core Business; Raises Outlook for 2010

© Akorn, Inc. Lake Forest, Illinois, USA.

This web site is intended for informational purposes only and not intended to replace discussion with a healthcare provider.

If you have any questions regarding the content of this site please contact Akorn.

Opthalmics Injectables Specialty Therapeutics Contract Manufacturing